Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 2Renal Insufficiency, Chronic 1Renal Insufficiency 1Kidney Failure, Chronic 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 3Dexamethasone 2Bortezomib 2veliparib 1pembrolizumab 1isatuximab 1gallium 68 PSMA-11 1Whole-Body Irradiation 1Taxes 1Standard of Care 1Pluvicto 1Paclitaxel 1Kidney Transplantation 1Health Information Exchange 1Eplerenone 1Carboplatin 1Calcium Dobesilate 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Kidney Transplantation × 1 year × Clear all
NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC

Phase 1/2 Recruiting
90 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡